Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00WKK
|
|||
| Former ID |
DNC010698
|
|||
| Drug Name |
2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol
|
|||
| Synonyms |
CHEMBL1090794; 2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol; SCHEMBL1240366
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H23N3O2
|
|||
| Canonical SMILES |
C1COCCN1C(C2=CC=CC=C2)C(C3=CN=CC=C3)(C4=CN=CC=C4)O
|
|||
| InChI |
1S/C22H23N3O2/c26-22(19-8-4-10-23-16-19,20-9-5-11-24-17-20)21(18-6-2-1-3-7-18)25-12-14-27-15-13-25/h1-11,16-17,21,26H,12-15H2
|
|||
| InChIKey |
WPLZJOHYEBBPRT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated potassium channel Kv1.5 (KCNA5) | Target Info | Inhibitor | [1] |
| Pathwhiz Pathway | Muscle/Heart Contraction | |||
| Reactome | Voltage gated Potassium channels | |||
| WikiPathways | Potassium Channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2493-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.